Antibody-mediated neutralization of cytomegalovirus: Modulation of efficacy induced through the IgG constant region

Molecular Immunology

Volumn 38, Issue 11, 2002, Pages 833-840

  Furebring, Christina ^a   Speckner, Andrea ^b   Mach, Michael ^b   Sandlie, Inger ^c   Norderhaug, Lars ^c   Borrebaeck, Carl A K ^a   Turesson, Heléne ^a   Ohlin, Mats ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Complement; Cytomegalovirus; Hinge; IgG subclass; Neutralization

Indexed keywords

COMPLEMENT COMPONENT C1Q; EPITOPE; GLYCOPROTEIN B; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; RECOMBINANT ANTIBODY;

ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DRUG ACTIVITY; DRUG EFFICACY; HUMAN; HUMAN CELL; IMMUNOTHERAPY; PRIORITY JOURNAL; PROTEIN DOMAIN; VACCINATION; VIRUS NEUTRALIZATION;

ANTIBODIES, VIRAL; BASE SEQUENCE; COMPLEMENT SYSTEM PROTEINS; CYTOMEGALOVIRUS; HUMANS; IMMUNOGLOBULIN CONSTANT REGIONS; IMMUNOGLOBULIN G; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; RECOMBINANT PROTEINS; TUMOR CELLS, CULTURED;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 0036199486     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(01)00119-5     Document Type: Article

References (31)

1. Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q
2. Cell surface expression of human cytomegalovirus (HCMV) gp55-116 (gB): Use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody response
3. Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies
4. Antibody and virus: Binding and neutralization
5. Novel vectors for the expression of antibody molecules using variable regions generated by polymerase chain reaction
6. Role of the heavy chain constant domains in antibody-antigen interaction. Apparent specificity differences among streptococcal IgG antibodies expressing identical variable domains
7. Three-dimensional structure of a human fab with high affinity for tetanus toxoid
8. Evaluation of novel control elements by construction of eukaryotic expression vectors
9. Cooperative binding by mouse IgG3 antibodies: Implications for functional affinity, effector function and isotype restriction
10. Strain-specific neutralization of human cytomegalovirus isolates by human sera
11. Epitope analysis of human cytomegalovirus glycoprotein complexes using murine monoclonal antibodies
12. Real time analysis of antibody-antigen reaction kinetics
13. Antibodies to recombinant-derived glycoprotein B after natural human cytomegalovirus infection correlate with neutralizing activity
14. The gp116 of the gp58/116 complex of human cytomegalovirus represents the amino-terminal part of the precursor molecule and contains a neutralizing epitope
15. Glycoprotein gp116 of human cytomegalovirus contains epitopes for strain-common and strain-specific antibodies
16. Human IgG subclass pattern of inducing complement-mediated cytolysis depends on antigen concentration and to a lesser extent on epitope patchiness, antibody affinity and complement concentration, antibody affinity and complement concentration
17. Chimeric mouse human IgG3 antibodies with an IgG4-like hinge region induce complement-mediated lysis more efficiently than IgG3 with normal hinge
18. Neutralizing mechanisms of two human monoclonal antibodies against human cytomegalovirus glycoprotein 130/55
19. Fine specificity of the human immune response to the major neutralization epitopes expressed on cytomegalovirus gp58/116 (gB), as determined with human monoclonal antibodies
20. Restricted variable region gene usage and possible rheumatoid factor relationship among human monoclonal antibodies specific for the AD-1 epitope on cytomegalovirus glycoprotein B
21. Light chain shuffling of a high affinity antibody results in a drift in epitope recognition
22. Cytomegalovirus glycoprotein B-specific antibody analysis using electrochemiluminescence detection-based techniques
23. Comparisons of the ability of human IgG3 hinge mutants, IgM, IgE and IgA2, to form small immune complexes: A role for flexibility and geometry
24. Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1
25. Antibodies specific for the antigenic domain 1 of glycoprotein B (gpUL55) of human cytomegalovirus bind to different substructures
26. Human cytomegalovirus structural proteins
27. Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV)
28. Altered expression of host-encoded complement regulators on human cytomegalovirus-infected cells
29. Epitope-specific distribution of IgG subclasses against antigenic domains on glycoproteins of human cytomegalovirus
30. A continuous sequence of more than 70 amino acids is essential for antibody binding to the dominant antigenic site of glycoprotein gp58 of human cytomegalovirus
31. Cytomegaloviruses use multiple mechanisms to elude the host immune response